IAVI Trials Database - IAVI - International AIDS Vaccine Initiative

V526-001 MRKAd5 and MRKAd6 HIV-1 Trigene Vaccines

Safety and Immunogenicity of the MRKAd5 and MRKAd6 HIV-1 Trigene Vaccines Alone and in Combination in Healthy Adults

Phase:	I	Status:	Completed
Organizer developer:	Merck	Start Date:	May 01, 2005
Product:	MRKAd5 HIV-1 gag/pol/nef,MRKAd5+6 HIV-1,MRKAd6	Antigen:	Ad5 Gag,pol,nef; Ad5 & Ad6 Nef, gag, pol B; Ad6 Gag,pol,nef B
Prime 1:	MRKAd5 HIV-1 gag/pol/nef	Prime Class:	Viral Vector - Adeno
Boost 1:	MRKAd6	Boost 1 class:	Viral Vector - Adeno
Boost 2:	MRKAd5+6 HIV-1	Boost 2 Class:	Viral Vector - Adeno
Boost 3:		Boost 3 Class:
Adjuvant:
Country:	USA	Volunteers:	146
ClinicalTrials.gov Identifier:	NCT00850616
Link: http://clinicaltrials.gov/ct2/show/NCT00850616